Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Rebeccamycin Derivatives as Dual DNA-Damaging Agents and Potent Checkpoint Kinase 1 Inhibitors

Christelle Marminon, Fabrice Anizon, Pascale Moreau, Bruno Pfeiffer, Alain Pierré, Roy M. Golsteyn, Paul Peixoto, Marie-Paule Hildebrand, Marie-Hélène David-Cordonnier, Olivier Lozach, Laurent Meijer and Michelle Prudhomme
Molecular Pharmacology December 2008, 74 (6) 1620-1629; DOI: https://doi.org/10.1124/mol.108.049346
Christelle Marminon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabrice Anizon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascale Moreau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Pfeiffer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Pierré
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roy M. Golsteyn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Peixoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Paule Hildebrand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Hélène David-Cordonnier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Lozach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Meijer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Prudhomme
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 74 no. 6 1620-1629
DOI 
https://doi.org/10.1124/mol.108.049346
PubMed 
18768386

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received May 29, 2008
  • Accepted September 2, 2008
  • Published online November 17, 2008.

Article Versions

  • Earlier version (September 2, 2008 - 12:24).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Christelle Marminon,
  2. Fabrice Anizon,
  3. Pascale Moreau,
  4. Bruno Pfeiffer,
  5. Alain Pierré,
  6. Roy M. Golsteyn1,
  7. Paul Peixoto,
  8. Marie-Paule Hildebrand,
  9. Marie-Hélène David-Cordonnier,
  10. Olivier Lozach,
  11. Laurent Meijer and
  12. Michelle Prudhomme
  1. Laboratoire SEESIB, Université Blaise Pascal, Unité Mixte de Recherche 6504 du Centre National de la Recherche Scientifique, Aubière, France (C.M., S.M., F.A., P.M., M.P.); Institut de Recherches Servier, Division Recherche Cancérologie, Croissy sur Seine, France (B.P., A.P., R.M.G.); Institut National de la Santé et de la Recherche Médicale U837, Centre de Recherches Jean-Pierre Aubert, Team “Molecular and Cellular Targeting for Cancer Treatment” (P.P., M.-P.H., M.-H.D.-C.) and Université de Lille 2, Lille, France (P.P., M.-P.H., M.-H.D.-C.); and Station Biologique Cell Cycle Group, Roscoff, France (O.L., L.M.)
  1. Address correspondence to:
    Prof. Michelle Prudhomme, Université Blaise Pascal, UMR 6504 du CNRS, Laboratoire de Synthèse Et Etudes de Systèmes à Intérêt Biologique, 24 Avenue des Landais, 63177 Aubière, France. E-mail: michelle.prudhomme{at}univ-bpclermont.fr
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2008 to March 2023

AbstractFullPdf
Sep 20081130105
Oct 200847034
Nov 200861948
Dec 2008471124
Jan 200919713
Feb 20093658
Mar 200944712
Apr 20092557
May 20091474
Jun 20099210
Jul 200925113
Aug 20091926
Sep 20091444
Oct 20092108
Nov 20091621
Dec 20092811
Jan 20104025
Feb 20102786
Mar 2010171611
Apr 20103319
May 2010182816
Jun 20102018
Jul 201011104
Aug 20101843
Sep 2010241516
Oct 20101279
Nov 201019710
Dec 2010789
Jan 2011976
Feb 2011161818
Mar 2011131613
Apr 2011876
May 201112616
Jun 201123815
Jul 2011131719
Aug 2011191816
Sep 2011271317
Oct 2011202020
Nov 2011301813
Dec 2011221115
Jan 201218926
Feb 2012271417
Mar 2012382025
Apr 2012201218
May 2012301413
Jun 2012251410
Jul 2012191419
Aug 20122099
Sep 2012381012
Oct 2012241321
Nov 201234910
Dec 20122067
Jan 2013321211
Feb 201336165
Mar 20133686
Apr 2013303622
May 2013302427
Jun 20131945
Jul 20132023
Aug 201316712
Sep 20132799
Oct 2013441220
Nov 2013231914
Dec 2013164880
Jan 2014382824
Feb 2014291411
Mar 2014381325
Apr 2014422116
May 2014301614
Jun 2014281018
Jul 201433812
Aug 20141658
Sep 2014401213
Oct 2014351216
Nov 201418175
Dec 201431118
Jan 201514109
Feb 2015201112
Mar 201531113
Apr 20152562
May 20153398
Jun 20152268
Jul 201534138
Aug 201520138
Sep 20151066
Oct 20152863
Nov 201521810
Dec 20152256
Jan 201623318
Feb 201635013
Mar 201625215
Apr 20161206
May 20161966
Jun 201625513
Jul 2016231011
Aug 2016171112
Sep 20161279
Oct 201651015
Nov 201691013
Dec 2016194
Jan 2017398
Feb 20170118
Mar 201721818
Apr 20170169
May 201701326
Jun 2017177
Jul 20170129
Aug 201711611
Sep 2017055
Oct 201721410
Nov 20170166
Dec 201722616
Jan 20181277
Feb 20181144
Mar 201821411
Apr 201812812
May 201841116
Jun 20180105
Jul 20180107
Aug 20180135
Sep 2018094
Oct 201811110
Nov 2018297
Dec 201814610
Jan 2019301
Feb 2019978
Mar 20192407
Apr 2019902
May 20191007
Jun 20192707
Jul 20191008
Aug 20191803
Sep 20192700
Oct 20191414
Nov 20191301
Dec 20192302
Jan 20202122
Feb 20201414
Mar 2020601
Apr 20201412
May 2020901
Jun 2020810
Jul 2020900
Aug 2020311
Sep 2020621
Oct 20201102
Nov 2020706
Dec 20201105
Jan 2021913
Feb 20211215
Mar 20212110
Apr 20211910
May 2021942
Jun 20211100
Jul 2021913
Aug 2021531
Sep 2021322
Oct 20211230
Nov 2021612
Dec 20211526
Jan 20221911
Feb 2022711
Mar 2022910
Apr 20221210
May 2022712
Jun 20221240
Jul 20221315
Aug 2022811
Sep 2022812
Oct 2022811
Nov 20221512
Dec 2022310
Jan 20231011
Feb 2023831
Mar 20231700

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 74 (6)
Molecular Pharmacology
Vol. 74, Issue 6
1 Dec 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Rebeccamycin Derivatives as Dual DNA-Damaging Agents and Potent Checkpoint Kinase 1 Inhibitors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Rebeccamycin Derivatives as Dual DNA-Damaging Agents and Potent Checkpoint Kinase 1 Inhibitors

Christelle Marminon, Fabrice Anizon, Pascale Moreau, Bruno Pfeiffer, Alain Pierré, Roy M. Golsteyn, Paul Peixoto, Marie-Paule Hildebrand, Marie-Hélène David-Cordonnier, Olivier Lozach, Laurent Meijer and Michelle Prudhomme
Molecular Pharmacology December 1, 2008, 74 (6) 1620-1629; DOI: https://doi.org/10.1124/mol.108.049346

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Rebeccamycin Derivatives as Dual DNA-Damaging Agents and Potent Checkpoint Kinase 1 Inhibitors

Christelle Marminon, Fabrice Anizon, Pascale Moreau, Bruno Pfeiffer, Alain Pierré, Roy M. Golsteyn, Paul Peixoto, Marie-Paule Hildebrand, Marie-Hélène David-Cordonnier, Olivier Lozach, Laurent Meijer and Michelle Prudhomme
Molecular Pharmacology December 1, 2008, 74 (6) 1620-1629; DOI: https://doi.org/10.1124/mol.108.049346
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics